Achyut Healthcare Ltd
ACHYUTAchyut Healthcare Ltd
ACHYUT
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
AvgAverage profitability - not good, not bad
Entry point
BadThe stock is in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 3.57 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 52.56 | 6.72 | 0.47% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Achyut Healthcare Limited is an India-based company, which is engaged in trading of pharmaceutical business. The Company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products. The Company is into the trading business in both domestic as well as international markets in the countries namely United Arab Emirates (UAE), Kenya and Nigeria.
Peers
Compare with peersHemant Surgical Industries Ltd
Royal Sense Ltd
Chandra Bhagat Pharma Ltd
Dipna Pharmachem Ltd
Checkpoint Trends Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.67 | 0.34 | 0.27 | 4.19 | 3.29 | 6.87 | — | |||||||
Raw Materials | 0.55 | 0.18 | 0.33 | 3.35 | 2.15 | 5.27 | — | |||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Employee Cost | 0.01 | 0.01 | 0.00 | 0.04 | 0.07 | 0.11 | ||||||||
| Selling & Administrative Expenses | 0.09 | 0.14 | 0.02 | 0.59 | 0.88 | 0.41 | ||||||||
| Operating & Other expenses | -0.00 | -0.01 | -0.09 | 0.11 | -0.13 | 0.32 | ||||||||
EBITDA | 0.02 | 0.02 | 0.01 | 0.10 | 0.32 | 0.76 | — | |||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | — | |||||||
| PBIT | 0.02 | 0.02 | 0.01 | 0.09 | 0.31 | 0.75 | — | |||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||||
| PBT | 0.02 | 0.02 | 0.01 | 0.09 | 0.31 | 0.75 | — | |||||||
| Taxes & Other Items | 0.03 | 0.00 | 0.00 | 0.06 | 0.08 | 0.17 | — | |||||||
| Net Income | -0.01 | 0.02 | 0.01 | 0.03 | 0.23 | 0.58 | — | |||||||
| EPS | -0.06 | 0.12 | 0.07 | 0.05 | 0.19 | 0.38 | — | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Health CareHealth Care Distributors
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Achyut Healthcare Ltd | 189.08 | 3.57 | — |
| Hemant Surgical Industries Ltd | 16.29 | 2.91 | — |
| Royal Sense Ltd | 66.15 | 25.34 | — |
| Chandra Bhagat Pharma Ltd | 34.36 | 1.79 | — |
Price Comparison
Compare ACHYUT with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 8.97%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Apr 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
ACHYUT has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeAchyut Healthcare will hold a meeting of the Board of Directors of the Company on 19 October 2024.Powered by Capital Market - Live
Achyut Healthcare announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Achyut Healthcare will hold a meeting of the Board of Directors of the Company on 2 September 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 59.29%, vs industry avg of 16.25%
Increasing Market Share
Over the last 5 years, market share increased from 0.27% to 1.25%